PAR 1.79% 27.5¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Update and Appendix 4C - quarterly, page-28

  1. 820 Posts.
    lightbulb Created with Sketch. 328
    Hi All,
    some further observations / musing's from poolside..

    1. Does anybody know what "top-line data" actually means and will they be released to the market?
    2. It would be interesting to know if the confidential dataroom holds any of the up to date preliminary results from 008.
    3. With 65 sites (excluding Europe) surely this will enhance patient enrollment and maybe reduce the current timelines (subject to Covid resurgence). Donna has said previously that the current timelines are conservative.

    Eitherway I'm glad PR is still our Chairman as he has a large vested interest and is still deeply passionate. By stepping back he can focus on the strategy, leaving the CEO and Operations folks to deal with the noise. Lets hope they continue to articulate their progress a little better.

    My money is on a deal shortly after 008 top-line, which funds us through to an earlyer that anticipated registration (I know its a BIO and thats unlikely but Im throwing it out to the universe). Now I just need to find FarmerBob to confirm.... If you are out their Bob we need some of your insights.

    My wife has had an expectation of an invitation to the Country Club (as a member) for some time now and Im struggling to keep her from looking at my share trading account.... Come on PAR.

    Pool out.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.